These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2056136)

  • 21. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.
    Oosthuizen P; Emsley R; Jadri Turner H; Keyter N
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):125-31. PubMed ID: 15003147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
    Dysken MW; Kim SW; Vatassery G; Johnson SB; Skare S; Holden L; Thomsyck L
    J Clin Psychopharmacol; 1992 Apr; 12(2):128-32. PubMed ID: 1573034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choreiform movements induced by anticholinergic therapy.
    West RR; Newgreen DB
    Med J Aust; 1979 Jul; 2(2):87-8. PubMed ID: 492035
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
    Winslow RS; Stillner V; Coons DJ; Robison MW
    Am J Psychiatry; 1986 Jun; 143(6):706-10. PubMed ID: 2872822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    Sachdev P; Tang WM
    Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
    Siris SG; Rifkin A; Reardon GT; November M
    Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the need for anticholinergic medication in patients treated with long-term antipsychotics.
    Caradoc-Davies G; Menkes DB; Clarkson HO; Mullen PE
    Aust N Z J Psychiatry; 1986 Jun; 20(2):225-32. PubMed ID: 2876700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage of haloperidol for mania.
    Rifkin A; Doddi S; Karajgi B; Borenstein M; Munne R
    Br J Psychiatry; 1994 Jul; 165(1):113-6. PubMed ID: 7953013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders.
    Janicak PG; Javaid JI; Sharma RP; Leach A; Dowd S; Davis JM
    Acta Psychiatr Scand; 1997 Apr; 95(4):343-50. PubMed ID: 9150830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of maintenance use of anticholinergic agents.
    Double DB; Warren GC; Evans M; Rowlands RP
    Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute dystonia during fixed-dose neuroleptic treatment.
    Singh H; Levinson DF; Simpson GM; Lo ES; Friedman E
    J Clin Psychopharmacol; 1990 Dec; 10(6):389-96. PubMed ID: 2286708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal haloperidol dosage in first-episode psychosis.
    Zhang-Wong J; Zipursky RB; Beiser M; Bean G
    Can J Psychiatry; 1999 Mar; 44(2):164-7. PubMed ID: 10097837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haloperidol: twenty years' clinical experience.
    Ayd FJ
    J Clin Psychiatry; 1978 Nov; 39(11):807-14. PubMed ID: 721784
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
    De Cuyper H; Bollen J; van Praag HM; Verstraeten D
    Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benztropine for the relief of acute non-traumatic neck pain (wry neck): a randomised trial.
    Asha SE; Kerr A; Jones K; McAlpine A
    Emerg Med J; 2015 Aug; 32(8):616-9. PubMed ID: 25414475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-responsive symptoms during early neuroleptic treatment.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.